
|Articles|October 20, 2015
Efficacy of Ozurdex in DME in the real world clinical setting-DeSmet Interview
Professor Marc De Smet talks about the impact of Ozurdex in treating diabetic macular edema (DME) in the real world clinical setting. This renowned expert in the DME field, explores what the licensing of Ozurdex in DME means to both patients and retinal specialists when treating this potentially blinding condition.
Advertisement
Redirect to video article
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA accepts resubmitted ONS-5010 BLA from Outlook Therapeutics
2
Five-year GALE study data announced
3
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
4
AAO 2025: Effect of cryopreserved amniotic membrane after corneal cross-linking in patients with keratoconus
5



















































.png)


